Clear Search

Books+ Search Results

Subject: "Drugs."
Author/Creator: Is
Is Is Not
United States
Language: Is
Is Is Not
English
Subject: Is
Is Is Not
United States. Food and Drug Administration

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (124)

Limit your search

-
Current results range from 1955 to 2023

1.
Regulation of over-the-counter drugs : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-sixth Congress, first session, June 22, 1979
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. Govt. Print. Off., 1979.
Location
Library Shelving Facility (LSF) >> Y 4.In 8/4:96-44
Format
Books
2.
"Man-in-the-plant", FDA's failure to regulate deceptive drug labeling : hearings before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Commerce, House of Representatives, Ninety-fifth Congress, second session, September 8 and 12, 1978
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. Govt. Print. Off., 1978.
Location
Library Shelving Facility (LSF) >> Y 4.In 8/4:95-140
Format
Books
3.
Ensuring drug safety where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Ensuring drug safety : where do we go from here? : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining the Food and Drug Administration's process of ensuring drug safety, March 3, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-75
Format
Books
5.
Regulation of prescription drug advertising. Thirty-ninth report by the Committee on Government Operations. December 10, 1970. -- Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
Author
United States. Congress. House. Committee on Government Operations. (1952- )
Published
Washington, DC, 1970
Online
Online text
Location
Yale Internet Resource >> None
Format
Books / Online
6.
Building a 21st century FDA : proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-850
Format
Books
7.
Building a 21st century FDA proposals to improve drug safety and innovation : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, second session, on examining proposals to improve drug safety and innovation, and S. 3807, to amend the Public Health Service Act and the Federal Food, Drug, and Cosmetic Act to improve drug safety and oversight, November 16, 2006
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2007.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Rare diseases : expediting treatments for patients : hearing before the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining rare diseases, focusing on expediting treatments for patients, October 3, 2018
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.115-851
Format
Books
9.
Rare diseases : expediting treatments for patients : hearing before the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining rare diseases, focusing on expediting treatments for patients, October 3, 2018
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo146785
Location
Yale Internet Resource >> None
Format
Books / Online
10.
Drug user fees enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O., 2008.
Online
http://purl.access.gpo.gov/GPO/LPS103984
Location
Yale Internet Resource >> None
Format
Books / Online
11.
Drug user fees : enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.110-384
Format
Books
12.
Drug user fees enhancing patient access and drug safety : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Tenth Congress, first session, on examining enhancing patient access and drug safety relating to prescription drug user fees, including S. 484, March 14, 2007
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2008.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
13.
Drug listing act of 1972. June 27 (legislative day, June 26), 1972. -- Ordered to be printed
Author
United States. Congress. Senate. Committee on Labor and Public Welfare. (1947-1977)
Published
Washington, DC, 1972
Online
Online text
Location
Yale Internet Resource >> None
Format
Books / Online
14.
Drug listing act of 1971. August 2, 1971. -- Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. (1892- 1981)
Published
Washington, DC, 1971
Online
Online text
Location
Yale Internet Resource >> None
Format
Books / Online
15.
Prioritizing public health : the FDA's role in the generic drug marketplace : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fourteenth Congress, second session : special hearing, September 21, 2016, Washington, DC
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.AP 6/2:S.HRG.114-694
Format
Books
16.
FDA's drug approval process up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Online
Online resource
Location
Yale Internet Resource >> None
Format
Books / Online
17.
FDA's drug approval process : up to the challenge? : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Ninth Congress, first session, on examining Food and Drug Administration's (FDA) drug approval process, focusing on FDA's drug approval process after a sponsor demonstrates that their benefits outweigh their risks for a specific population and use, and that the drug meet [sic] meets standards for safety and efficacy, March 1, 2005
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2005.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.109-67
Format
Books
18.
Role of commissioner of food and drugs : hearing before the Committee on Labor and Human Resources, United States Senate, One Hundred Second Congress, first session, on examining the role of the current commissioner of the Food and Drug Administration, March 6, 1991
Author
United States. Congress. Senate. Committee on Labor and Human Resources
Published
Washington : U.S. G.P.O. : For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office, 1992.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.hrg.102-446
Format
Books
19.
"Man-in-the-plant" revisited, a deceptive drug labeling practice continues : hearing before the Subcommittee on Oversight and Investigations of the Committee on Interstate and Foreign Committee, House of Representatives, Ninety-sixth Congress, second session, March 6, 1980
Author
United States. Congress. House. Committee on Interstate and Foreign Commerce. Subcommittee on Oversight and Investigations
Published
Washington : U.S. Govt. Print. Off., 1980.
Location
Library Shelving Facility (LSF) >> Y 4.In 8/4:96-140
Format
Books
20.
Improving animal health : reauthorization of FDA animal drug user fees : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fifteenth Congress, second session, on examining improving animal health, focusing on reauthorization of Food and Drug Administration animal drug user fees, February 13, 2018
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2020.
Location
Library Shelving Facility (LSF) >> Y 4.L 11/4:S.HRG.115-777
Format
Books
21.
The Quayle Council's plans for changing FDA's drug approval process : a prescription for harm : twenty-sixth report
Author
United States. Congress. House. Committee on Government Operations
Published
Washington : U.S. G.P.O., 1992.
Location
Law Library >> KF3871 .U54 1992
Format
Books
22.
Federal food, drug, and cosmetic act, with amendments
Author
United States
Published
Washington : U.S. G.P.O., 1976.
Location
Library Shelving Facility (LSF) >> S 26 F73 1976
Format
Books
23.
False and misleading advertising (prescription tranquilizing drugs). Thirty-ninth report by the Committee on Government Operations. August 18, 1958. -- Committed to the Committee of the Whole House on the State of the Union and ordered to be printed
Author
United States. Congress. House. Committee on Government Operations. (1952- )
Published
Washington, DC, 1958
Online
Online text
Location
Yale Internet Resource >> None
Format
Books / Online
24.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O., 2011.
Online
http://purl.fdlp.gov/GPO/gpo4112
Location
Yale Internet Resource >> None
Format
Books / Online
25.
Food and Drug Administration's review process for products to treat rare diseases and neglected tropical diseases : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Eleventh Congress, second session, special hearing, June 23, 2010, Washington, D.C.
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies
Published
Washington : U.S. G.P.O. : For sale by the Supt. of Docs., U.S. G.P.O., 2011.
Location
Library Shelving Facility (LSF) >> Y 4.AP 6/2:S.HRG.111-841
Format
Books